poisar

Stocks · News reference

Tempus AI Announces Initiative To Build Research Platform Containing 100K Whole Genomes Linked To Longitudinal Clinical Information Over Next Several Years

BenzingaBenzinga Newsdesk

The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longitudinal Clinical Outcomes, with a Long-Term Goal of Reaching 1 Million GenomesTempus AI, Inc. (NASDAQ:TEM) today

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading